rezoom2 - Have you done any research on the past employment history of Erck and members of the NVAX BOD? I seem to recall he positioned a previous Biotech for buyout, as did other members of the BOD/Executive team. One has to wonder how long Mr. Erck will want to continue involvement in the Biotech industry at his current age.
Tenthoff?...Never heard of him. Has he ever been on CNBC or Bloomberg?
Bill & Melinda Gates...Yeah, they're successful and known to just about every human on Earth.
ACRX has a full month of presentations in September. IMO this stock could easily double if good news is announced during that time.
I seriously doubt that most of the warrants, especially the ones at $0.01, were exercised and sold. I'm sure they were converted from the looks of the high volume days, but the guys holding these "new" shares aren't dummies. They know the potential to quadruple their profits in less than a year.
Yeah, I can see it behind the CNBC woman anchor's right side. Next week they'll be pointing at it as it reaches $5-$10/share
The $1 billion buyout of Sprout by Valeant was a done several weeks ago. Obviously, it was contingent upon FDA approval of ADDYI. The reporter mentioned there were other Big Pharma bidders interested, and Sprout agreed to go with the highest offer.
It makes me wonder who might be talking to PTN, and will PTN now seek FDA fast track status for bremelanotide?
I imagine much of PTN's float is already tightly held after looking at the historic volume over the past couple of months. I wonder if it has the potential to reach the all time high of $8.75 (pre-reverse split) over the next few days.